Emergent BioSolutions (EBS) Total Current Liabilities (2010 - 2026)
Emergent BioSolutions' Total Current Liabilities came in at $122.8 million for Q2 2026, down 3.4% from $127.1 million a year earlier and down 17.4% from the prior quarter.
Powered by 
Analysis
Emergent BioSolutions (EBS) Total Current Liabilities (2010 - 2026) Analysis & Trends
At the end of FY2025, Emergent BioSolutions' Total Current Liabilities was $132.2 million, down 18.6% from FY2024.
- Total Current Liabilities has declined in each of the last three years, with a five-year compound annual growth rate of -19.2% (FY2020 to FY2025).
- Going back by year, Total Current Liabilities was $162.4 million in FY2024 (-75.1%), $651.3 million in FY2023 (-47.0%), $1.23 billion in FY2022 (+228.6%) and $374 million in FY2021 (-2.7%).
- The Q2 2026 figure represents the lowest quarterly Total Current Liabilities since Q1 2025.
- Year-over-year, Total Current Liabilities increased in 1 of the last eight quarters, with an average decline of 41.5%.
- The fastest year-over-year change in Total Current Liabilities over five years came in Q1 2023 (growth of 387.8%), and the weakest in Q1 2025 (a decline of 82.2%).
- Business Quant data shows EBS's Total Current Liabilities at $148.7 million (Q1 2026), $132.2 million (Q4 2025) and $136.5 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,146.94 Bn | 1,115.53 Bn | 19.71 Bn | 47.74 Bn |
| 2 | Johnson & Johnson | 624.96 Bn | 543.49 Bn | 17.26 Bn | 54.90 Bn |
| 3 | AbbVie | 510.15 Bn | 483.27 Bn | 12.70 Bn | 41.64 Bn |
| 4 | Merck | 366.13 Bn | 320.51 Bn | 12.21 Bn | 27.73 Bn |
| 5 | Novartis Ag | 297.75 Bn | 261.74 Bn | 11.24 Bn | 31.75 Bn |
| 6 | Astrazeneca | 261.93 Bn | 235.62 Bn | 12.86 Bn | 31.55 Bn |
| 7 | Amgen | 236.51 Bn | 191.91 Bn | 7.24 Bn | 25.50 Bn |
| 8 | Gilead Sciences | 194.27 Bn | 168.47 Bn | 6.22 Bn | 11.02 Bn |
| 9 | Pfizer | 171.74 Bn | 118.39 Bn | 10.94 Bn | 32.65 Bn |
| 10 | Emergent BioSolutions | 325.34 Mn | -425.56 Mn | 137.20 Mn | 122.80 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 122.80 Mn |
| Mar 31, 2026 | 148.70 Mn |
| Dec 31, 2025 | 132.20 Mn |
| Sep 30, 2025 | 136.50 Mn |
| Jun 30, 2025 | 127.10 Mn |
| Mar 31, 2025 | 111.90 Mn |
| Dec 31, 2024 | 162.40 Mn |
| Sep 30, 2024 | 229.90 Mn |
| Jun 30, 2024 | 619.70 Mn |
| Mar 31, 2024 | 630.20 Mn |
| Dec 31, 2023 | 651.30 Mn |
| Sep 30, 2023 | 664.00 Mn |
| Jun 30, 2023 | 693.20 Mn |
| Mar 31, 2023 | 1.22 Bn |
| Dec 31, 2022 | 1.23 Bn |
| Sep 30, 2022 | 264.40 Mn |
| Jun 30, 2022 | 276.70 Mn |
| Mar 31, 2022 | 249.20 Mn |
| Dec 31, 2021 | 374.00 Mn |
| Sep 30, 2021 | 365.40 Mn |
API Access
Emergent BioSolutions Total Current Liabilities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=total-current-liabilities&ticker=EBS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "total-current-liabilities", "ticker": "EBS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=total-current-liabilities&ticker=EBS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();